Poseida Therapeutics
Melissa Johns has extensive experience in financial planning and analysis within the biotech and pharmaceutical industry. Melissa held roles at companies such as Poseida Therapeutics, Fate Therapeutics, Exelixis, Allergan, Tobira Therapeutics, Gilead Sciences, and Kabbage, Inc. Melissa'sresponsibilities ranged from financial operations to leading R&D finance teams, demonstrating a strong background in strategic financial management.
Melissa Johns earned a Bachelor of Science in Chemistry from The University of Georgia in 2001. Melissa went on to complete their MBA in Finance at Emory University - Goizueta Business School in 2013.
This person is not in any teams